To screen or not to screen: Conceptual issues in screening for psychiatric disorders in psychiatric patients with a focus on the performance of the psychiatric diagnostic screening questionnaire

International Journal of Mental Health and Addiction

Volumn 6, Issue 1, 2008, Pages 53-63

  Zimmerman, Mark ^a,b  

^a BROWN UNIVERSITY   (United States)

^b Bayside Medical Center   (United States)

Author keywords

Psychiatric diagnosis; Screening; Substance abuse

Indexed keywords

EID: 38949204071     PISSN: 15571874     EISSN: 15571882     Source Type: Journal    
DOI: 10.1007/s11469-007-9099-z     Document Type: Article

References (36)

1. Avrich, B. S., & Elkis, H. (2002). Prevalence and underrecognition of dysthymia among psychiatric outpatients in Sao Paulo, Brazil. Journal of Affective Disorders, 69, 193-199.
2. Basco, M. R., Bostic, J. Q., Davies, D., Rush, A. J., Witte, B., Hendrickse, W., et al. (2000). Methods to improve diagnostic accuracy in a community mental health setting. American Journal of Psychiatry, 157, 1599-1605.
3. Brown, R. A., Evans, D. M., Miller, I. W., Burgess, E. S., & Mueller, T. I. (1997). Cognitive-behavioral treatment for depression in alcoholism. Journal of Consulting and Clinical Psychology, 65, 715-726.
4. Castel, S., Rush, B., Kennedy, S., Fulton, K., & Toneatto, T. (2007). Screening for mental health problems among patients with substance use disorders. Preliminary findings on the validation of a self-assessment instrument. Canadian Journal of Psychiatry, 52(1), 22-27.
5. Cornelius, J., Salloum, I., Ehler, J., Jarrett, P., Cornelius, M., Perel, J., et al. (1997). Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. Archives of General Psychiatry, 54, 700-705.
6. Davidson, J., & Smith, R. (1993). Traumatic experiences in psychiatric outpatients. Journal of Traumatic Stress, 3, 459-475.
7. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1995). Structured clinical interview for DSM-IV Axis I disorders-Patient edition (SCID-I/P, version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.
8. Markowitz, J. C., Moran, M. E., Kocsis, J. H., & Frances, A. J. (1991). Prevalence and comordibity of dysthymic disorder among psychiatric outpatients. Journal of Affective Disorders, 24, 63-71.
9. McGrath, P., Nunes, E., Stewart, J., Goldman, D., Agosti, V., Ocepek-Welikson, K., et al. (1996). Imipramine treatment of alcoholics with primary depression. Archives of General Psychiatry, 53, 232-240.
10. Miller, P. R., Dasher, R., Collins, R., Griffiths, P., & Brown, F. (2001). Inpatient diagnostic assessments: 1. Accuracy of structured vs. unstructured interviews. Psychiatry Research, 105, 255-264.
11. Nunes, E. V., Quitkin, F. M., Donovan, S. J., Deliyannides, D., Ocepek-Welikson, K., Koenig, T., et al. (1998). Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial. Archives of General Psychiatry, 55, 153-160.
12. Pfohl, B., Blum, N., & Zimmerman, M. (1997). Structured interview for DSM-IV personality. Washington, DC: American Psychiatric.
13. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., et al. (1990). Comorbidity of mental disorders with alcohol and other drug use. Journal of the American Medical Association, 264, 2511-2518.
14. Ross, H. E., Glaser, F. B., & Germanson, T. (1988). The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Archives of General Psychiatry, 45, 1023-1031.
15. Roy-Byrne, P., Pages, K., Russo, J., Jaffe, C., Blume, A., Kingsley, E., et al. (2000). Nefazodone treatment of major depression in alcohol-dependent patients: A double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 20, 129-136.
16. Rush, A. J., Batey, S. R., Donahue, R., Ascher, J. A., Carmody, T. J., & Metz, A. (2001). Does pretreatment anxiety predict response to either bupropion SR or sertraline? Journal of Affective Disorders, 64, 81-87.
17. Sacks, S. (2007). Brief overview of screening and assessment for co-occurring disorders. International Journal of Mental Health and Addiction (this issue).
18. Shear, M. K., Greeno, C., Kang, J., Ludewig, D., Frank, E., Swartz, H. A., et al. (2000). Diagnosis of nonpsychotic patients in community clinics. American Journal of Psychiatry, 157, 581-587.
19. Sheehan, D. V., LeCrubier, Y., Sheehan, K. H., Amorin, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl. 20), 22-33.
20. Skinstad, A. H., & Swain, A. (2001). Comorbidity in a clinical sample of substance abusers. American Journal of Drug and Alcohol Abuse, 27, 45-64.
21. Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of PRIME MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. Journal of the American Medical Association, 282, 1737-1744.
22. Steiner, J. L., Tebes, J. K., Sledge, W. H., & Walker, M. L. (1995). A comparison of the Structured Clinical Interview for DSM-III-R and clinical diagnoses. Journal of Nervous and Mental Disease, 183, 365-369.
23. Tomasson, K., & Vaglum, P. (1995). A nationwide representative sample of treatment-seeking alcoholics: A study of psychiatric comorbidity. Acta Psychiatrica Scandinavica, 92, 378-385.
24. Triffleman, E., Carroll, K., & Kellogg, S. (1999). Substance dependence posttraumatic stress disorder therapy: An integral cognitive-behavioral approach. Journal of Substance Abuse Treatment, 17, 3-14.
25. Trivedi, M., Rush, A., Wisniewski, S., Nierenberg, A., Warden, D., Ritz, L., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D implications for clinical practice. American Journal of Psychiatry, 163, 28-40.
26. Zimmerman, M., & Chelminski, I. (2006). A scale to screen for axis I disorders in psychiatric outpatients: Performance of the Psychiatric Diagnostic Screening Questionnaire. Psychological Medicine, 36, 1601-1611.
27. Zimmerman, M., Jampala, V. C., Sierles, F. S., & Taylor, M. A. (1993). DSM-III and DSM-IIIR: What are American psychiatrists using and why? Comprehensive Psychiatry, 181, 360-364.
28. Zimmerman, M., & Mattia, J. I. (1999a). Differences between clinical and research practice in diagnosing borderline personality disorder. American Journal of Psychiatry, 156, 1570-1574.
29. Zimmerman, M., & Mattia, J. I. (1999b). Psychiatric diagnosis in clinical practice: Is comorbidity being missed? Comprehensive Psychiatry, 40, 182-191.
30. Zimmerman, M., & Mattia, J. I. (1999c). The reliability and validity of a screening questionnaire for 14 DSM-IV Axis I disorder (The Psychiatric Diagnostic Screening Questionnaire). Journal of Clinical Psychiatry, 60, 677-683.
31. Zimmerman, M., & Mattia, J. I. (1999d). Is posttraumatic stress disorder underdiagnosed in routine clinical settings? Journal of Nervous and Mental Disease, 187, 420-428.
32. Zimmerman, M., & Mattia, J. I. (2000). Principal and additional DSM-IV disorders for which outpatients seek treatment. Psychiatric Services, 51, 1299-1304.
33. Zimmerman, M., & Mattia, J. I. (2001a). The Psychiatric Diagnostic Screening Questionnaire: Development, reliability and validity. Comprehensive Psychiatry, 42, 175-189.
34. Zimmerman, M., & Mattia, J. I. (2001b). A self-report scale to help make psychiatric diagnoses: The Psychiatric Diagnostic Screening Questionnaire (PDSQ). Archives of General Psychiatry, 58, 787-794.
35. Zimmerman, M., & Sheeran, T. (2003). Screening for principal versus comorbid conditions in psychiatric outpatients with the Psychiatric Screening Questionnaire. Psychological Assessment, 15, 110-114.
36. Zimmerman, M., Sheeran, T., Chelminski, I., & Young, D. (2004). Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. Journal of Substance Abuse Treatment, 26, 181-188.